1 - 25 of 35 results for uniprot:A6XAA7 in Computationally mapped citations
Results Customize
| Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate. Mangold E., Ludwig K.U., Birnbaum S., Baluardo C., Ferrian M., Herms S., Reutter H., de Assis N.A., Chawa T.A., Mattheisen M. et al. Nat. Genet. 42:24-26(2010) GAD 597766 · Mapped (14) |
| Drm/Gremlin transcriptionally activates p21(Cip1) via a novel mechanism and inhibits neoplastic transformation. Chen B., Athanasiou M., Gu Q., Blair D.G. Biochem. Biophys. Res. Commun. 295:1135-1141(2002) GeneRIF 26585 · Mapped (9) |
| Gremlin - a putative pathogenic player in progressive renal disease. Dolan V., Murphy M., Alarcon P., Brady H.R., Hensey C. Expert Opin. Ther. Targets 7:523-526(2003) GeneRIF 26585 · Mapped (3) |
| Bone morphogenetic protein antagonists Drm/Gremlin and Dan interact with Slits and act as negative regulators of monocyte chemotaxis. Chen B., Blair D.G., Plisov S., Vasiliev G., Perantoni A.O., Chen Q., Athanasiou M., Wu J.Y., Oppenheim J.J., Yang D. J. Immunol. 173:5914-5917(2004) GeneRIF 26585 · UniProtKB (3) · Mapped (5) |
| Skeletal overexpression of gremlin impairs bone formation and causes osteopenia. Gazzerro E., Pereira R.C., Jorgetti V., Olson S., Economides A.N., Canalis E. Endocrinology 146:655-665(2005) GeneRIF 26585 · Mapped (6) |
| Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy. Dolan V., Murphy M., Sadlier D., Lappin D., Doran P., Godson C., Martin F., O'Meara Y., Schmid H., Henger A. et al. Am. J. Kidney Dis. 45:1034-1039(2005) GeneRIF 26585 · Mapped (12) |
| DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers. Suzuki M., Shigematsu H., Shames D.S., Sunaga N., Takahashi T., Shivapurkar N., Iizasa T., Frenkel E.P., Minna J.D., Fujisawa T. et al. Br. J. Cancer 93:1029-1037(2005) GeneRIF 26585 · Mapped (11) |
| The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein. Namkoong H., Shin S.M., Kim H.K., Ha S.A., Cho G.W., Hur S.Y., Kim T.E., Kim J.W. BMC Cancer 6:74-74(2006) GeneRIF 26585 · Mapped (8) |
| Transcriptional profiling reveals novel markers of liver fibrogenesis: gremlin and insulin-like growth factor-binding proteins. Boers W., Aarrass S., Linthorst C., Pinzani M., Elferink R.O., Bosma P. J. Biol. Chem. 281:16289-16295(2006) GeneRIF 26585 · Mapped (6) |
| Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Sneddon J.B., Zhen H.H., Montgomery K., van de Rijn M., Tward A.D., West R., Gladstone H., Chang H.Y., Morganroth G.S., Oro A.E. et al. Proc. Natl. Acad. Sci. U.S.A. 103:14842-14847(2006) GeneRIF 26585 · Mapped (8) |
| Regulation of myogenic progenitor proliferation in human fetal skeletal muscle by BMP4 and its antagonist Gremlin. Frank N.Y., Kho A.T., Schatton T., Murphy G.F., Molloy M.J., Zhan Q., Ramoni M.F., Frank M.H., Kohane I.S., Gussoni E. J. Cell Biol. 175:99-110(2006) GeneRIF 26585 · Mapped (5) |
| Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis. Mezzano S., Droguett A., Burgos M.E., Aros C., Ardiles L., Flores C., Carpio D., Carvajal G., Ruiz-Ortega M., Egido J. Nephrol. Dial. Transplant. 22:1882-1890(2007) GeneRIF 26585 · Mapped (3) |
| Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis. Myllarniemi M., Lindholm P., Ryynanen M.J., Kliment C.R., Salmenkivi K., Keski-Oja J., Kinnula V.L., Oury T.D., Koli K. Am. J. Respir. Crit. Care Med. 177:321-329(2008) GeneRIF 26585 · Mapped (15) |
| Co-regulation of Gremlin and Notch signalling in diabetic nephropathy. Walsh D.W., Roxburgh S.A., McGettigan P., Berthier C.C., Higgins D.G., Kretzler M., Cohen C.D., Mezzano S., Brazil D.P., Martin F. Biochim. Biophys. Acta 1782:10-21(2008) GeneRIF 26585 · Mapped (7) |
| Elevated levels of gremlin-1 in eutopic endometrium and peripheral serum in patients with endometriosis. Sha G., Zhang Y., Zhang C., Wan Y., Zhao Z., Li C., Lang J. Fertil. Steril. 91:350-358(2009) GeneRIF 26585 · Mapped (3) |
| Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension. Costello C.M., Howell K., Cahill E., McBryan J., Konigshoff M., Eickelberg O., Gaine S., Martin F., McLoughlin P. Am. J. Physiol. Lung Cell Mol. Physiol. 295:L272-84(2008) GeneRIF 26585 · Mapped (6) |
| Gremlin enhances the determined path to cardiomyogenesis. Kami D., Shiojima I., Makino H., Matsumoto K., Takahashi Y., Ishii R., Naito A.T., Toyoda M., Saito H., Watanabe M. et al. PLoS ONE 3:e2407-e2407(2008) GeneRIF 26585 · Mapped (6) |
| Bone morphogenetic protein 4 inhibits TGF-beta2 stimulation of extracellular matrix proteins in optic nerve head cells: role of gremlin in ECM modulation. Zode G.S., Clark A.F., Wordinger R.J. Glia 57:755-766(2009) GeneRIF 26585 · Mapped (8) |
| High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men. Yerges L.M., Klei L., Cauley J.A., Roeder K., Kammerer C.M., Moffett S.P., Ensrud K.E., Nestlerode C.S., Marshall L.M., Hoffman A.R. et al. J. Bone Miner. Res. 24:2039-2049(2009) GeneRIF 26585 · Mapped (1,348) |
| No breast cancer association for transforming growth factor-beta pathway colorectal cancer single nucleotide polymorphisms. Gibson L., Johnson N., Fraser A., dos Santos Silva I., Houlston R., Peto J., Fletcher O. Cancer Epidemiol. Biomarkers Prev. 18:1934-1936(2009) GeneRIF 26585 GAD 567962 · Mapped (6) |
| Evaluation of gremlin 1 (GREM1) as a candidate susceptibility gene for albuminuria-related traits in Mexican Americans with type 2 diabetes mellitus. Thameem F., Puppala S., He X., Arar N.H., Stern M.P., Blangero J., Duggirala R., Abboud H.E. Metab. Clin. Exp. 58:1496-1502(2009) GeneRIF 26585 · Mapped (3) |
| Levels of expression for BMP-7 and several BMP antagonists may play an integral role in a fracture nonunion: a pilot study. Fajardo M., Liu C.J., Egol K. Clin. Orthop. Relat. Res. 467:3071-3078(2009) GeneRIF 26585 · Mapped (13) |
| Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinoma. van Vlodrop I.J., Baldewijns M.M., Smits K.M., Schouten L.J., van Neste L., van Criekinge W., van Poppel H., Lerut E., Schuebel K.E., Ahuja N. et al. Am. J. Pathol. 176:575-584(2010) GeneRIF 26585 · Mapped (3) |
| A GREM1 gene variant associates with diabetic nephropathy. McKnight A.J., Patterson C.C., Pettigrew K.A., Savage D.A., Kilner J., Murphy M., Sadlier D., Maxwell A.P. J. Am. Soc. Nephrol. 21:773-781(2010) GeneRIF 26585 · Mapped (3) |
| Genomic rearrangements of the GREM1-FMN1 locus cause oligosyndactyly, radio-ulnar synostosis, hearing loss, renal defects syndrome and Cenani--Lenz-like non-syndromic oligosyndactyly. Dimitrov B.I., Voet T., De Smet L., Vermeesch J.R., Devriendt K., Fryns J.P., Debeer P. J. Med. Genet. 47:569-574(2010) GeneRIF 26585 · Mapped (4) |

